Covid-19 vaccines in a neoliberal world
The first major outbreak of coronavirus happened almost two decades ago in the shape of SARs (severe acute respiratory syndrome), after which the virus continue to appear from time to…
The first major outbreak of coronavirus happened almost two decades ago in the shape of SARs (severe acute respiratory syndrome), after which the virus continue to appear from time to…
Hailed this week as a pandemic game-changer, the new Covid-19 vaccine offered countries that had pre-ordered doses a potential escape from a cycle of lockdowns and new waves of sickness…
As early as February, with the global pandemic spreading fast, the World Health Organization issued a warning about an “infodemic”, a wave of fake news and misinformation about the deadly…
The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved…
Britain hailed “V-Day” when it became the first country to roll out the Pfizer-BioNTech COVID-19 vaccine. Yet, as first mover, it has also become the first to report cases of…
Hui Min NEO with Yannick Pasquet in Hamburg and Michelle Fitzpatrick and Yann Schreiber in Mainz It was over breakfast on the wintry morning of January 24 that Ozlem Tureci…
‘The global scheme to deliver COVID-19 vaccines to poorer countries faces a “very high” risk of failure, potentially leaving nations home to billions of people with no access to vaccines…
Since the Omicron variant of Covid-19 was detected, the stark global inequities that have characterised this pandemic have once again come to the forefront. From discriminatory travel bans to limited…
‘Ensuring widespread global access to Covid-19 vaccines, which is necessary for preventing cases and deaths and contributing to global population immunity, is a critical challenge and one that could threaten…
‘But while hundreds of millions of vaccine doses have been administered globally, there are deep disparities. In high-income countries, vaccine supplies are sufficient to provide for around one in four…